616 results on '"Feller, Alfred"'
Search Results
2. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
3. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
4. Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
5. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
6. Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
7. Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
8. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation
9. Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
10. Genome-wide DNA methylation-analysis delineates blastic plasmacytoid dendritic cell neoplasm from related entities and identifies distinct molecular features
11. Basal cell carcinoma with neuroendocrine differentiation arising in a scar: A case report
12. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
13. Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
14. Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining
15. Primary refractory plasmablastic lymphoma: A precision oncology approach
16. Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
17. A modular transcriptome map of mature B cell lymphomas
18. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
19. Genome-Wide DNA Methylation Profiling in Blastic Plasmacytoid Dendritic Cell Neoplasm
20. Practical Guidelines for Lymphoma Diagnosis in Bone Marrow
21. Lymphoma Occurring in a Setting of Immunodeficiency
22. Practical Advice: Methods for the Diagnosis of Malignant Lymphoma
23. Plasma Cell Proliferations
24. Nodal and Leukemic NK/T-Cell Lymphoma
25. Extranodal Lymphoma
26. Nodal B-Cell Lymphoma
27. Current Status of Lymphoma Classification
28. History of Lymphoma Classification
29. Epidemiology
30. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte‐predominant Hodgkin lymphoma
31. TP53 mutation and survival in aggressive B cell lymphoma
32. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
33. Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma
34. Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
35. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
36. B-Cell Lymphomas
37. The Kiel Classification
38. T-Cell Lymphomas
39. The Diagnosis of Lymphoma
40. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
41. Comparative analysis of international prognostic indices in gray-zone lymphoma
42. Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
43. Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
44. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
45. Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group
46. A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein
47. Oncogenic Mutations and Chromosomal Aberrations in Primary Extranodal Diffuse Large B-Cell Lymphomas of the Thyroid—A Study of 21 Cases
48. MicroRNA Profiling of Low-Grade and Transformed Nodal Marginal Zone Lymphoma Reveals a Similar Signature Pattern Distinct from Diffuse Large B Cell Lymphoma
49. XIAP variants in male Crohnʼs disease
50. Oncogenic MYD88 Mutations Are Rare Events in Double-Hit B-Cell Lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.